1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Libman-Sacks Disease in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (22.22) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cederholm, A; Concha, H; FrostegÄrd, J; Hua, X; Su, J; Svenungsson, E | 1 |
Chang, HT; Chen, JS; Cheng, HH; Ho, CM; Hsu, SS; Huang, CJ; Huang, JK; Jan, CR; Jiann, BP; Lo, YK; Yeh, JH | 1 |
McDonald, EG; Pelczar-Wissner, CJ; Sussman, II | 1 |
Barquinero, J; Khamashta, M; Ordi-Ros, J; Perez-Peman, P; Selva, A; Vilardell, M | 1 |
Bussolati, B; Camussi, G; Mariano, F; Quarello, F; Rollino, C | 1 |
Ben-Bassat, M; Blank, M; Krause, I; Shoenfeld, Y | 1 |
Baldi, E; Dunn, MJ; Emancipator, SN; Hassan, MO | 1 |
Benfenati, E; Macconi, D; Noris, M; Pagliarino, G; Quaglia, R; Remuzzi, G | 1 |
Fuse, I; Hanano, M; Hattori, A; Higashihara, M; Koike, T; Nagayama, R; Shibata, A; Takahashi, H; Takeshige, T; Takizawa, S | 1 |
9 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Libman-Sacks Disease
Article | Year |
---|---|
Natural antibodies against phosphorylcholine as potential protective factors in SLE.
Topics: Adult; Autoantibodies; Binding, Competitive; Cardiovascular Diseases; Cross Reactions; Endothelium, Vascular; Female; Hemocyanins; Humans; Immunoglobulin G; Intercellular Adhesion Molecule-1; Lupus Erythematosus, Systemic; Middle Aged; Phosphorylcholine; Platelet Activating Factor; Serum Albumin, Bovine; Severity of Illness Index; Vascular Cell Adhesion Molecule-1 | 2008 |
Defect in regulation of Ca2+ movement in platelets from patients with systemic lupus erythematosus.
Topics: Adenosine Diphosphate; Arachidonic Acid; Blood Platelets; Calcium; Calcium Signaling; Female; Fluorescent Dyes; Fura-2; Humans; Lupus Erythematosus, Systemic; Patients; Platelet Activating Factor; Thrombin | 2005 |
Absence of platelet activating factor (PAF) mediated platelet aggregation: a new platelet defect.
Topics: Adult; Blood Coagulation Factors; Epinephrine; Female; Humans; Lupus Erythematosus, Systemic; Platelet Activating Factor; Platelet Aggregation; Thrombin | 1984 |
Antibodies against platelet-activating factor in patients with antiphospholipid antibodies.
Topics: Antibodies, Antiphospholipid; Antibody Specificity; Antiphospholipid Syndrome; Autoantibodies; Humans; Lupus Coagulation Inhibitor; Lupus Erythematosus, Systemic; Platelet Activating Factor; Syphilis | 1994 |
IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE).
Topics: Adult; Biomarkers; Female; Humans; Interleukin-10; Lupus Erythematosus, Systemic; Male; Monocytes; Platelet Activating Factor; Proteinuria | 2000 |
Induction of experimental anti-phospholipid syndrome associated with SLE following immunization with human monoclonal pathogenic anti-DNA idiotype.
Topics: Animals; Antibodies, Anticardiolipin; Antibodies, Antinuclear; Antiphospholipid Syndrome; Body Weight; Cross Reactions; Disease Models, Animal; Female; Fetal Resorption; Lupus Erythematosus, Systemic; Mice; Mice, Inbred BALB C; Organ Size; Phospholipids; Placenta; Platelet Activating Factor; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Vaccination | 1992 |
Platelet activating factor receptor blockade ameliorates murine systemic lupus erythematosus.
Topics: Animals; Female; Furans; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred Strains; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1990 |
Increased urinary excretion of platelet activating factor in mice with lupus nephritis.
Topics: Animals; Gas Chromatography-Mass Spectrometry; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Mutant Strains; Platelet Activating Factor | 1991 |
A defect of platelet release reaction in a patient with SLE: impaired platelet aggregation induced by phorbol ester with a normal phosphorylation of 40K protein.
Topics: Adenosine Diphosphate; Adult; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Blood Proteins; Calcimycin; Collagen; Diglycerides; Epinephrine; Female; Humans; Lupus Erythematosus, Systemic; Phorbols; Phosphorylation; Platelet Activating Factor; Platelet Aggregation; Tetradecanoylphorbol Acetate; Thrombin | 1986 |